Psychedelics in problem-solving experiment

Last updated

Psychedelic agents in creative problem-solving experiment was a study designed to evaluate whether the use of a psychedelic substance with supportive setting can lead to improvement of performance in solving professional problems. The altered performance was measured by subjective reports, questionnaires, the obtained solutions for the professional problems and psychometric data using the Purdue Creativity, the Miller Object Visualization, and the Witkins Embedded Figures tests. [1] This experiment was a pilot that was to be followed by control studies as part of exploratory studies on uses for psychedelic drugs, that were interrupted early in 1966 when the Food and Drug Administration declared a moratorium on research with human subjects, as a strategy in combating illicit use. [2]

Contents

Contemporary follow-up

In 2008 psychedelics researcher Ben Sessa published an article reviewing the idea to study if psychedelics could have effect of creativity as suggested by many anecdotes. Sessa considered similarities between theories of creativity and mind states caused by psychedelics and shortly reviewed few experiments from the 1950s and 1960s that studied mostly the effect of LSD on creativity. Sessa considered that among the few studies available the study done by Harman et al. in 1966 deserved closer attention as it had the most consideration for beneficial set & setting for both creativity and psychedelic experience. Sessa considered the 1966 experiment to be severely limited in not being double blind and placebo controlled. He also considered that recreating the 1966 experiment using modern research methods might have benefits for furthering understanding of neuroscience. [3]

See also

Related Research Articles

Lysergic acid diethylamide Hallucinogenic drug

Lysergic acid diethylamide (LSD), also known colloquially as acid, is a psychedelic drug. Effects typically include intensified thoughts, emotions, and sensory perception. At sufficiently high dosages LSD manifests primarily visual, as well as auditory, hallucinations. Dilated pupils, increased blood pressure, and increased body temperature are typical. Since LSD binds to dopamine receptors in addition to serotonin receptors its effects are also more energetic and fast-paced compared to psychedelics such as psilocybin, which is not a dopamine agonist. Effects typically begin within half an hour and can last for up to 20 hours. LSD is also capable of occasioning mystical experiences and ego dissolution, albeit less frequently than compounds such as psilocybin. It is used mainly as a recreational drug or for spiritual reasons. LSD is both the prototypical psychedelic and one of the 'classical' psychedelics, being the psychedelics with the greatest scientific and cultural significance.

Psilocybin Chemical compound found in some species of mushrooms

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of fungi. The most potent are members of the genus Psilocybe, such as P. azurescens, P. semilanceata, and P. cyanescens, but psilocybin has also been isolated from about a dozen other genera. As a prodrug, psilocybin is quickly converted by the body to psilocin, which has mind-altering effects similar, in some aspects, to those of LSD, mescaline, and DMT. In general, the effects include euphoria, visual and mental hallucinations, changes in perception, a distorted sense of time, and perceived spiritual experiences. It can also include possible adverse reactions such as nausea and panic attacks.

Psychedelic drug Hallucinogenic class of psychoactive drug

Psychedelics are a class of hallucinogenic drugs whose primary effect is to trigger non-ordinary states of consciousness via serotonin 2A receptor agonism. This causes specific psychological, visual and auditory changes, and often a substantially altered state of consciousness. The "classical" psychedelics, the psychedelics with the largest scientific and cultural influence, are mescaline, LSD, psilocybin, and DMT.

Creativity Phenomenon whereby something new and somehow valuable is formed

Creativity is a phenomenon whereby something new and valuable is formed. The created item may be intangible or a physical object.

Psychedelic therapy refers to therapeutic practices involving psychedelic drugs such as LSD, psilocybin, DMT, mescaline, 2C-B, and MDMA. In psychedelic therapy, in contrast to the use of conventional psychiatric medication which is taken by the patient regularly or as-needed, patients remain in an extended psychotherapy session during the acute activity of the drug and spend the night at the facility. In the sessions with the drug, therapists are nondirective and support the patient in exploring their inner experience. Patients participate in psychotherapy before the drug psychotherapy sessions to prepare them and after the drug psychotherapy to help them integrate their experiences with the drug.

Creativity techniques are methods that encourage creative actions, whether in the arts or sciences. They focus on a variety of aspects of creativity, including techniques for idea generation and divergent thinking, methods of re-framing problems, changes in the affective environment and so on. They can be used as part of problem solving, artistic expression, or therapy.

History of lysergic acid diethylamide

The psychedelic drug lysergic acid diethylamide (LSD) was first synthesized on November 16, 1938 by the Swiss chemist Albert Hofmann in the Sandoz laboratories in Basel, Switzerland. It was not until five years later on April 19, 1943, that the psychedelic properties were found.

The Multidisciplinary Association for Psychedelic Studies (MAPS) is an American nonprofit organization working to raise awareness and understanding of psychedelic substances. MAPS was founded in 1986 by Rick Doblin and is now based in San Jose, California.

Insight is the understanding of a specific cause and effect within a particular context. The term insight can have several related meanings:

Myron Stolaroff

Myron J. Stolaroff was an author and researcher who is best known for his studies involving psychedelic psychotherapy. He also conducted clinical studies that attempted to measure the effects of LSD, mescaline, and other drugs on creativity.

Microdosing, or micro-dosing, is a technique for studying the behaviour of drugs in humans through the administration of doses so low ("sub-therapeutic") they are unlikely to produce whole-body effects, but high enough to allow the cellular response to be studied. This is called a "Phase 0 study" and is usually conducted before clinical Phase I to predict whether a drug is viable for the next phase of testing. Human microdosing aims to reduce the resources spent on non-viable drugs and the amount of testing done on animals.

The Beckley Foundation is a UK-based think tank and UN-accredited NGO, dedicated to activating global drug policy reform and initiating scientific research into psychoactive substances. The foundation is a charitable trust which collaborates with leading scientific and political institutions worldwide to design and develop research and global policy initiatives. It also investigates consciousness and its modulation from a multidisciplinary perspective, working in collaboration with scientists. The foundation is based at Beckley Park near Oxford, United Kingdom. It was founded in 1998, and is directed by Amanda Feilding, Countess of Wemyss.

Amanda Feilding, Countess of Wemyss and March is an English drug policy reformer, lobbyist, and research coordinator. In 1998, she founded the Foundation to Further Consciousness, later renamed to the Beckley Foundation, a charitable trust which initiates, directs, and supports neuroscientific and clinical research into the effects of psychoactive substances on the brain and cognition. She has also co-authored over 50 papers published in peer-reviewed journals, according to the Foundation. The central aim of her research is to investigate new avenues of treatment for such mental illnesses as depression, anxiety, and addiction, as well as to explore methods of enhancing well-being and creativity.

Computational creativity Multidisciplinary endeavour

Computational creativity is a multidisciplinary endeavour that is located at the intersection of the fields of artificial intelligence, cognitive psychology, philosophy, and the arts.

A hallucinogen is a psychoactive agent that often or ordinarily causes hallucinations, perceptual anomalies, and other substantial subjective changes in thought, emotion, and consciousness that are not typically experienced to such degrees with other drug classifications. The term hallucinogen almost invariably refers to any drug which causes what is called a "trip". The common classifications for hallucinogens are psychedelics, dissociatives and deliriants. Although hallucinogens all can induce altered states of consciousness with some overlap in effects, there are quantifiable as well as vast qualitative differences in the induced subjective experiences between the different classes of hallucinogens due to differing and distinct pharmacological mechanisms. Contemporarily, certain potentially hallucinogenic GABAergic drugs such as muscimol, gaboxadol and zolpidem may be grouped into a distinct, separate or new category of hallucinogens that may be referred to as hypnotics despite many hypnotic and GABAergic drugs not being hallucinogenic like the three previously mentioned compounds. Additionally, cannabinergic compounds may also be considered distinct from the other categories as well despite sharing characteristics; specifically with both the psychedelic and dissociative classes.

Placebo-controlled study

Placebo-controlled studies are a way of testing a medical therapy in which, in addition to a group of subjects that receives the treatment to be evaluated, a separate control group receives a sham "placebo" treatment which is specifically designed to have no real effect. Placebos are most commonly used in blinded trials, where subjects do not know whether they are receiving real or placebo treatment. Often, there is also a further "natural history" group that does not receive any treatment at all.

LSD art is any art or visual displays inspired by psychedelic experiences and hallucinations known to follow the ingestion of LSD. Artists and scientists have been interested in the effect of LSD on drawing and painting since it first became available for legal use and general consumption.

The Remote Associates Test (RAT) is a creativity test used to determine a human's creative potential. The test typically lasts forty minutes and consists of thirty to forty questions each of which consists of three common stimulus words that appear to be unrelated. The person being tested must think of a fourth word that is somehow related to each of the first three words. Scores are calculated based on the number of correct questions.

James Fadiman is an American writer. He is acknowledged for his research on microdosing psychedelics. He co-founded, along with Robert Frager, the Institute of Transpersonal Psychology, which later became Sofia University, where he was a lecturer in psychedelic studies.

Psychedelic microdosing is the practice of using sub-threshold doses (microdoses) of serotonergic psychedelic drugs in an attempt to improve creativity, boost physical energy level, promote emotional balance, increase performance on problems-solving tasks and to treat anxiety, depression and addiction. The practice of microdosing has become more widespread in the 21st century with more people claiming long-term benefits from the practice.

References

  1. Harman, W. W.; McKim, R. H.; Mogar, R. E.; Fadiman, J.; Stolaroff, M. J. (1966). "Psychedelic agents in creative problem-solving: A pilot study". Psychological Reports. 19 (1): 211–227. doi:10.2466/pr0.1966.19.1.211. PMID   5942087. S2CID   16508547.
  2. Tim Doody's article "The heretic" about doctor James Fadiman 's experiments on psychedelics and creativity
  3. Sessa, Ben (2008). "Is it time to revisit the role of psychedelic drugs in enhancing human creativity?". Journal of Psychopharmacology. 22 (8): 821–827. doi:10.1177/0269881108091597. PMID   18562421. S2CID   1908638.